Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduction of Fas/CD95 Promoter Methylation, Upregulation of Fas Protein, and Enhancement of Sensitivity to Apoptosis in Cutaneous T-Cell Lymphoma
Jianqiang Wu, Gary S. Wood
Archives of Dermatology (2010) Vol. 147, Iss. 4, pp. 443-443
Closed Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma*
Werner Kempf, Katrin Pfaltz, Maarten H. Vermeer, et al.
Blood (2011) Vol. 118, Iss. 15, pp. 4024-4035
Open Access | Times Cited: 393
Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors
Kun Qu, Lisa C. Zaba, Ansuman T. Satpathy, et al.
Cancer Cell (2017) Vol. 32, Iss. 1, pp. 27-41.e4
Open Access | Times Cited: 158
Targeting the Fas/FasL signaling pathway in cancer therapy
María Villa‐Morales, José Fernández‐Piqueras
Expert Opinion on Therapeutic Targets (2012) Vol. 16, Iss. 1, pp. 85-101
Closed Access | Times Cited: 148
Cutaneous T‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2015) Vol. 91, Iss. 1, pp. 151-165
Open Access | Times Cited: 139
Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy
Marie de Charette, Roch Houot
Haematologica (2018) Vol. 103, Iss. 8, pp. 1256-1268
Open Access | Times Cited: 89
The paradigm of drug resistance in cancer: an epigenetic perspective
Swagata Adhikari, Apoorva Bhattacharya, Santanu Adhikary, et al.
Bioscience Reports (2022) Vol. 42, Iss. 4
Open Access | Times Cited: 45
Aberrant DNA methylation as a key modulator of cell death pathways: insights into cancer progression and other diseases
Ambreen Zahoor, Rafia Khazer, Insha Mehraj, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access | Times Cited: 1
DNA Methylation and Apoptosis Resistance in Cancer Cells
Éric Hervouet, Mathilde Cheray, François M. Vallette, et al.
Cells (2013) Vol. 2, Iss. 3, pp. 545-573
Open Access | Times Cited: 92
Epigenetic biomarkers in skin cancer
Edward S. Greenberg, Kelly K. Chong, Kelly Huynh, et al.
Cancer Letters (2012) Vol. 342, Iss. 2, pp. 170-177
Open Access | Times Cited: 79
Cutaneous T‐cell lymphoma: 2014 Update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2014) Vol. 89, Iss. 8, pp. 837-851
Open Access | Times Cited: 67
Epigenetic Deregulation of Apoptosis in Cancers
Ezgi Ozyerli‐Goknar, Tugba Bagcı-Önder
Cancers (2021) Vol. 13, Iss. 13, pp. 3210-3210
Open Access | Times Cited: 53
Apoptosis evasion via long non-coding RNAs in colorectal cancer
Muhammad Irfan, Zeeshan Javed, Khushbukhat Khan, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 28
Cutaneous T‐cell lymphoma: 2011 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2011) Vol. 86, Iss. 11, pp. 928-948
Open Access | Times Cited: 71
Methotrexate and Pralatrexate
Gary S. Wood, Jianqiang Wu
Dermatologic Clinics (2015) Vol. 33, Iss. 4, pp. 747-755
Open Access | Times Cited: 52
Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
Kalyani Patil, Shilpa Kuttikrishnan, Abdul Quaiyoom Khan, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 382-399
Open Access | Times Cited: 40
Much more than you expected: The non-DHFR-mediated effects of methotrexate
Martin Šrámek, Jakub Neradil, Renata Veselská
Biochimica et Biophysica Acta (BBA) - General Subjects (2016) Vol. 1861, Iss. 3, pp. 499-503
Closed Access | Times Cited: 44
Preclinical Studies Support Combined Inhibition of BET Family Proteins and Histone Deacetylases as Epigenetic Therapy for Cutaneous T-Cell Lymphoma
Lei Zhao, Jean‐Phillip Okhovat, Eric Hong, et al.
Neoplasia (2018) Vol. 21, Iss. 1, pp. 82-92
Open Access | Times Cited: 42
SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis
Minakshi Nihal, Nihal Ahmad, Gary S. Wood
Cell Cycle (2013) Vol. 13, Iss. 4, pp. 632-640
Open Access | Times Cited: 43
T-cell lymphomas, a challenging disease: types, treatments, and future
Helen Ma, Maher Abdul‐Hay
International Journal of Clinical Oncology (2016) Vol. 22, Iss. 1, pp. 18-51
Open Access | Times Cited: 37
Molecular mechanisms in regulation of autophagy and apoptosis in view of epigenetic regulation of genes and involvement of liquid-liquid phase separation
Subhajit Chakraborty, Piyasa Nandi, Jagdish Mishra, et al.
Cancer Letters (2024) Vol. 587, pp. 216779-216779
Closed Access | Times Cited: 3
Alkylphosphocholines and curcumin induce programmed cell death in cutaneous T-cell lymphoma cell lines
Deyan Y. Yosifov, Kaloyan Kaloyanov, Margarita Guenova, et al.
Leukemia Research (2013) Vol. 38, Iss. 1, pp. 49-56
Closed Access | Times Cited: 33
Epigenetics in the treatment of systemic lupus erythematosus: Potential clinical application
Yu Guo, Amr H. Sawalha, Qianjin Lu
Clinical Immunology (2014) Vol. 155, Iss. 1, pp. 79-90
Closed Access | Times Cited: 30
Resistance of Sézary cells to TNF‐α‐induced apoptosis is mediated in part by a loss of TNFR1 and a high level of the IER3 expression
Oleg E. Akilov, Mei X. Wu, Irina V. Ustyugova, et al.
Experimental Dermatology (2012) Vol. 21, Iss. 4, pp. 287-292
Open Access | Times Cited: 28
The Fas apoptotic pathway in cutaneous T-cell lymphomas: Frequent expression of phenotypes associated with resistance to apoptosis
Nathalie Stutz, Ryan D. Johnson, Gary S. Wood
Journal of the American Academy of Dermatology (2012) Vol. 67, Iss. 6, pp. 1327.e1-1327.e10
Closed Access | Times Cited: 28
Methotrexate inhibits the viability of human melanoma cell lines and enhances Fas/Fas-ligand expression, apoptosis and response to interferon-alpha: Rationale for its use in combination therapy
Minakshi Nihal, Jianqiang Wu, Gary S. Wood
Archives of Biochemistry and Biophysics (2014) Vol. 563, pp. 101-107
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top